Please sign in to follow a disease.
Can a new rowing seat help veterans with paralysis row freely?
NCT ID NCT07099625
First seen Jul 24, 2026 · Last updated Jul 24, 2026
Summary
This trial compares two adaptive indoor rowing seats designed for Veterans who have limited trunk stability due to spinal cord injury, stroke, or neurodegenerative conditions. Participants will try both seats during short rowing sessions, and researchers will measure trunk movement, stroke length, power, and usability. The goal is to find a seat that allows full-stroke rowing, opening up a full-body exercise option that may improve physical and social well-being.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Adaptive indoor rowing seats (AIRS V2 and Paddle Sport adaptive seating system)
- What this could lead to
- If successful, this could lead to better adaptive rowing equipment that helps Veterans with limited trunk stability engage in full-body exercise, improving physical and mental well-being.
- What could go wrong
- This is a small, early-stage device comparison with only 15 participants, so results may not apply broadly. The on-market comparator seat is discontinued, which may limit relevance.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 15 people
The number the study aims to enrol. It can still change while the study runs.
- Expected to start
-
Oct 2026
An estimate. Start dates often move.
- Expected to finish
-
Dec 2028
An estimate. End dates often move.
- Lead sponsor
-
A government agency
The lead sponsor is a US federal agency other than the NIH.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Non-ventilator dependent paralysis, such as: * central nervous system impairment * spinal cord injuries with single neurological level in the cervical to lumbosacral region * cerebrovascular accident with associated sequelae including but not limited to hemiparesis and spasticity * neurodegenerative disorders including but not limited to amyotrophic lateral sclerosis, multiple sclerosis, multiple system atrophy, and parkinsonism * Poor trunk control/stability * Ability of body structure to fit within the limits of AIRS and the rowing system * Either volitional control of lower extremities or response/tolerance to electrical stimulation * Individuals who would be classified as PR2 or PR1 - FISA Para-Rowing Classifications Exclusion Criteria: * Veterans will be excluded if they have: * acute illness or injury * active or recent pressure injuries in the last 6 months affecting their ability to safely row (e.g., the coccyx, ischial tuberosity, sacrum, etc.) * Individuals who would be classified as NE or PR3-PD - FISA Para-Rowing Classifications * Flap procedure to address pressure injury less than one year prior * Upper extremity pain that restricts rowing * Surgical procedure within past 6 months that would make the study procedures unsafe (e.g., tendon repairs/transfers, neural decompressions, bony fusions, etc.) * Upper extremity or spine fractures within past 3 months, or longer if remains unstable/not fully healed. * Medical conditions such as cardiovascular disease, pulmonary disease, or other conditions that would make the study procedures unsafe pregnancy * Inability to communicate with the study team in real time * Inability to follow simple commands * Unable or unwilling to give consent
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Amyotrophic lateral sclerosis are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
2 sites. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Louis Stokes VA Medical Center, Cleveland, OH
Cleveland, Ohio, 44106-1702, United States
-
Minneapolis VA Health Care System, Minneapolis, MN
Minneapolis, Minnesota, 55417-2309, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Transcutaneous spinal stimulation with intensive physical therapy for locomotion
- A multicenter, open-label extension (OLE) study to evaluate the safety, pharmacodynamics, and clinical effects of WVE-004 in patients with C9orf72-associated amyotrophic lateral sclerosis (ALS) and/or frontotemporal dementia (FTD)
- Simulator-Based assessment of driving performance in patients with Parkinson's disease and multiple sclerosis
- Contrasting chronic inflammation and neurodegeneration using the human amniotic mesenchymal cell secretome as an innovative therapeutic strategy
- Early detrusor chemodenervation to preserve bladder compliance and longevity after spinal cord injury
- VIGIP-SEP2: evaluation of the impact of the training of patients by nurses on the adverse drug reaction reporting by RRMS patient via a mobile application: a randomized real-life study